KLA Corporation (KLAC) Stock Forecast
Data as of Sep 16, 2026Technology · Current price $167.59 (-0.92%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 13, 2026 | Chris Caso | Wolfe Research | $1800.00 | +974.0% |
| Mar 13, 2026 | Stacy Rasgon | Bernstein | $1835.00 | +994.9% |
| Jan 30, 2026 | Srini Pajjuri | RBC Capital | $1600.00 | +854.7% |
| Jan 30, 2026 | Brian Chin | Stifel Nicolaus | $1700.00 | +914.4% |
| Jan 30, 2026 | Stacy Rasgon | Bernstein | $1750.00 | +944.2% |
| Jan 30, 2026 | Joe Quatrochi | Wells Fargo | $1900.00 | +1033.7% |
| Jan 30, 2026 | Blayne Curtis | Jefferies | $1850.00 | +1003.9% |
| Jan 30, 2026 | Tom O'Malley | Barclays | $1700.00 | +914.4% |
| Jan 15, 2026 | Shane Brett | Morgan Stanley | $1694.00 | +910.8% |
| Jan 15, 2026 | Tom O'Malley | Barclays | $1595.00 | +851.7% |
| Jan 15, 2026 | Joe Quatrochi | Wells Fargo | $1600.00 | +854.7% |
| Jan 14, 2026 | Brian Chin | Stifel Nicolaus | $1600.00 | +854.7% |
| Jan 13, 2026 | Stacy Rasgon | Bernstein | $1700.00 | +914.4% |
| Oct 30, 2025 | Charles Shi | Needham | $1350.00 | +705.5% |
| Oct 30, 2025 | Tom O'Malley | Barclays | $1300.00 | +675.7% |
| Oct 20, 2025 | Tom O'Malley | Barclays | $1200.00 | +616.0% |
| Sep 22, 2025 | Shane Brett | Morgan Stanley | $1093.00 | +552.2% |
| Jul 10, 2025 | James Schneider | Goldman Sachs | $980.00 | +484.8% |
| May 1, 2025 | Edward Yang | Oppenheimer | $740.00 | +341.6% |
| Apr 15, 2025 | Brian Chin | Stifel Nicolaus | $750.00 | +347.5% |
Top Analysts Covering KLAC
KLAC vs Sector & Market
| Metric | KLAC | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.29 | 2.37 | 2.42 |
| Analyst Count | 35 | 14 | 18 |
| Target Upside | +23.6% | +1939.8% | +19.5% |
| P/E Ratio | 47.44 | 38.30 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-30 | $15.11B | $16.54B | $17.16B | 20 |
| 2027-09-30 | $4.31B | $4.44B | $4.56B | 6 |
| 2027-12-31 | $4.34B | $4.48B | $4.60B | 6 |
| 2028-03-31 | $4.45B | $4.59B | $4.71B | 5 |
| 2028-06-30 | $4.53B | $4.67B | $4.79B | 5 |
| 2028-09-30 | $4.62B | $4.77B | $4.89B | 6 |
| 2028-12-31 | $4.73B | $4.88B | $5.00B | 8 |
| 2029-03-31 | $4.61B | $4.75B | $4.87B | 9 |
| 2029-06-30 | $4.67B | $4.81B | $4.94B | 9 |
| 2030-06-30 | $22.79B | $24.33B | $25.42B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2027-06-30 | $45.18 | $48.44 | $50.92 | 16 |
| 2027-09-30 | $12.92 | $13.46 | $13.90 | 6 |
| 2027-12-31 | $13.03 | $13.57 | $14.01 | 6 |
| 2028-03-31 | $13.56 | $14.12 | $14.59 | 7 |
| 2028-06-30 | $13.86 | $14.44 | $14.91 | 7 |
| 2028-09-30 | $14.01 | $14.59 | $15.07 | 7 |
| 2028-12-31 | $14.18 | $14.77 | $15.25 | 7 |
| 2029-03-31 | $13.60 | $14.16 | $14.62 | 10 |
| 2029-06-30 | $13.69 | $14.26 | $14.73 | 9 |
| 2030-06-30 | $69.10 | $75.29 | $79.69 | 2 |
Frequently Asked Questions
What is the analyst consensus for KLAC?
The consensus among 35 analysts covering KLA Corporation (KLAC) is Buy with an average price target of $225.50.
What is the highest price target for KLAC?
The highest price target for KLAC is $1900.00, set by Joe Quatrochi at Wells Fargo on 2026-01-30.
What is the lowest price target for KLAC?
The lowest price target for KLAC is $365.00, set by Blayne Curtis at Barclays on 2022-04-29.
How many analysts cover KLAC?
35 analysts have issued ratings for KLA Corporation in the past 12 months.
Is KLAC a buy or sell right now?
Based on 35 analyst ratings, KLAC has a consensus rating of Buy (2.29/5) with a +23.6% upside to the consensus target of $225.50.
What are the earnings estimates for KLAC?
Analysts estimate KLAC will report EPS of $48.44 for the period ending 2027-06-30, with revenue estimated at $16.54B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.